Well - Dr P definitely hopes that OnCARlytics will be a "universal" treatment for cancer.
Also - when asked if they are looking at developing other versions, he did say that they are investigating other options pre-clinically but that the current CD19 version will hopefully "be sufficient." ie. - again - a one size fits all treatment for cancer.
Extremely positive presentation.
Cheers
Dave
Ann: Imugene Investor Webinar - FDA IND Clearance for onCARlytics, page-33
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $357.0M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $279.2K | 5.733M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 94 | 12992150 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 1795056 | 6 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |